Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorSoylemez U.G.
dc.contributor.authorCelebiler H.K.
dc.contributor.authorHarkonen J.
dc.contributor.authorBakir-Gungor B.
dc.date.accessioned2024-02-04T13:30:11Z
dc.date.available2024-02-04T13:30:11Z
dc.date.issued2022
dc.identifier.isbn9781665488945
dc.identifier.urihttps://doi.org/10.1109/ASYU56188.2022.9925401
dc.identifier.urihttp://hdl.handle.net/11446/4862
dc.description2022 Innovations in Intelligent Systems and Applications Conference, ASYU 2022 -- 7 September 2022 through 9 September 2022 -- -- 183936en_US
dc.description.abstractFirst-trimester maternal screening is a widely used test for detecting fetal aneuploidies and neural tube defects for over two decades. Human chorionic gonadotropin hormone (beta-hCG) and pregnancy-associated plasma protein A (PAPP-A) are two serum biomarkers that are analyzed in this screening. The thyroid hormone is a critical hormone for normal pregnancy and fetal development. During the first half of pregnancy, placental and fetal development depends on the thyroid hormone levels in the mother. Therefore, thyroid abnormalities in the mother can result in unfavorable pregnancy outcomes such as intrauterine growth restriction, miscarriage, hypertensive disorders, premature birth, and an increase in the risk of low IQ in the newborn. In this study, we analyzed the first-trimester screening data collected from 410 pregnant women who were seen at Yale University Hospital Prenatal Unit; and checked for possible correlations of TSH levels with maternal characteristics, racial group PAPP-A MoM levels. © 2022 IEEE.en_US
dc.language.isoengen_US
dc.publisherInstitute of Electrical and Electronics Engineers Inc.en_US
dc.relation.ispartofProceedings - 2022 Innovations in Intelligent Systems and Applications Conference, ASYU 2022en_US
dc.identifier.doi10.1109/ASYU56188.2022.9925401
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectFree ß-hCGen_US
dc.subjectPAPP-Aen_US
dc.subjectThyroid Stimulating Hormoneen_US
dc.subjectAneuploidyen_US
dc.subjectFetal aneuploidyen_US
dc.subjectFetal developmenten_US
dc.subjectFirst trimestersen_US
dc.subjectFree ß-hCGen_US
dc.subjectPlasma proteinen_US
dc.subjectPregnancy-associated plasma protein Aen_US
dc.subjectProtein Aen_US
dc.subjectThyroid hormonesen_US
dc.subjectThyroid stimulating hormonesen_US
dc.subjectObstetricsen_US
dc.titleThe relationship between TSH levels, maternal characteristics and racial group of the aneuploidy screeningen_US
dc.typeconferenceObjecten_US
dc.departmentDBÜen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.department-tempSoylemez, U.G., Mus Alparslan University, Faculty of Engineering and Architecture, Department of Software Engineering, Mus, Turkey; Celebiler, H.K., School of Medicine, Istanbul Bilim University, Department of Pediatrics, Istanbul, Turkey; Harkonen, J., Sociology European University Institute, Florence, Italy; Bakir-Gungor, B., School of Engineering, Abdullah Gul University, Department of Computer Engineering, Kayseri, Turkeyen_US
dc.identifier.scopus2-s2.0-85142684137en_US
dc.authorscopusid57576344400
dc.authorscopusid15032986100
dc.authorscopusid37053968200
dc.authorscopusid25932029800


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster